Share
Tyler Binney
Imperative Care, Inc., a medical technology leader focused on advancing care for stroke and other vascular conditions, has appointed Tyler Binney to its Board of Directors.
The addition of Binney brings seasoned leadership and a proven track record of scaling healthcare companies through innovation, operational discipline, and strategic transactions.
Binney most recently served as President and CEO of Relievant Medsystems, where he led the company’s commercial expansion and was instrumental in its successful $850+ million acquisition by Boston Scientific. Under his leadership, Relievant emerged as a frontrunner in the treatment of chronic low back pain, transforming its market presence and clinical impact.
Prior to Relievant, Binney held several influential executive roles, including President and GM of Interventional Urology at Teleflex and Vice President of Sales at NeoTract. At NeoTract, he was a key figure in the company’s strategic growth and $1.1 billion acquisition by Teleflex, underscoring his strength in scaling commercial operations and leading high-value M&A activities.
Currently, Binney serves as Chairman of the Board at iO Urology and holds board seats at Intrinsic Therapeutics and ProVerum Medical, further extending his influence in medtech innovation and commercialization.
His appointment to the Imperative Care board comes at a critical time as the company expands its portfolio of integrated stroke and vascular solutions and accelerates its mission to deliver next-generation outcomes in neurovascular care.
Binney’s deep understanding of scaling businesses and navigating complex healthcare ecosystems will be instrumental in guiding Imperative Care’s next phase of innovation, partnerships, and global impact.
Related posts
